Speaker Biographies Doug Edgeton, M PH, M BA President and CEO, NC Biotechnology Center Doug Edgeton became NCBiotech’s president and CEO in September 2014. He brings extensive executive-­‐level experience in health care from major academic medical centers, research park development and business administration, including an emphasis on community service. Throughout his career, Edgeton has managed both human resources (talent) and facilities, helping them work in concert to create the right ecosystem for organizational growth. This approach led to more efficient organizations, faster technology transfer and better patient care. Edgeton continues this approach at the NCBiotech Center, targeting state investment and staff expertise to help North Carolina’s life science companies grow, create jobs and bring life-­‐changing technologies to market. He joined NCBiotech in 2012 as senior vice president for financial planning and development. He was responsible for the top-­‐to-­‐bottom examination of programs, staffing and finances following a 27 percent cut to the Center’s state appropriation in 2013. The examination was led by a Board of Directors committee, chaired by former GlaxoSmithKline Chairman Bob Ingram, at the request of the General Assembly and resulted in an addition of $1 million to the Center’s state appropriation. Edgeton received his B.S. degree from the University of Alabama in Tuscaloosa, and MPH and MBA degrees from University of Alabama-­‐ Birmingham. Edgeton has extensive involvement in professional, community and civic organizations, and currently serves on the Salem Academy and College Board of Visitors. U.S. Rep. David Price (D-­‐NC) 4th Congressional District David Price represents North Carolina's Fourth District -­‐ a rapidly growing, research-­‐
and-­‐education-­‐focused district that includes parts of Alamance, Orange, Durham, Wake, Harnett, Chatham and Cumberland counties. He received his undergraduate degree at University of North Carolina -­‐ Chapel Hill and went on to Yale University to earn a Bachelor of Divinity and Ph.D. in Political Science. Before he began serving in Congress in 1987, Price was a professor of Political Science and Public Policy at Duke University. He is the author of four books on Congress and the American political system. (Continued) U.S. Rep. David Price (D-­‐NC) 4th Congressional District (Continued) Price currently serves on the House Appropriations Committee and is the ranking member of the Homeland Security Appropriations Subcommittee. He is also a member of the Appropriations subcommittees covering housing and transportation and military construction and veterans affairs. He is a recognized leader in foreign policy, co-­‐chairing the House Democracy Partnership, which he initiated to help strengthen parliaments in emerging democracies. In North Carolina, David's constituents know him as a strong supporter of education, accessible health care, affordable housing, clean air and water and improved transportation alternatives. David is a native of Erwin, Tennessee. He and his wife Lisa live in Chapel Hill and are parents of two children and proud grandparents of a grandson born in 2006 and a granddaughter born in 2009. Aldona W os, M D State Department of Health and Human Services Secretary Governor Pat McCrory appointed Aldona Zofia Wos, MD, to serve as Secretary of the North Carolina Department of Health and Human Services (DHHS), effective January 5, 2013. Dr. Wos was born in Warsaw, Poland. She earned her medical degree at the Warsaw Medical Academy, and completed her internship and residency in Internal Medicine and a fellowship in Pulmonary Medicine in New York. Her experiences include time as a physician in private practice, corporate medicine, attending physician duties, clinical care, teaching and consulting for both hospitals and private industry. Dr. Wos was nominated by President George W. Bush in 2004 to serve as U.S. Ambassador to the Republic of Estonia. She concluded her tour as Ambassador on December 17, 2006. During her tenure, Ambassador Wos focused on winning the hearts and minds of the next generation of Estonian leaders, Russian integration, HIV/AIDS prevention, and the preservation of Estonian culture. Dr. Wos is the daughter of Paul Zenon Wos, who is a survivor of Flossenburg Concentration Camp, former member of the Polish Home Army (AK) and recipient of “Righteous Among the Nations” medal from Yad Vashem, among other distinguished awards. As a child of a survivor, Dr. Wos is passionate about presenting and preserving full and accurate information about the Polish experience during World War II. Dr. Wos served two terms on the United States Holocaust Memorial Council. Dr. Wos has served on the UNC Board of Governors and on numerous boards of philanthropic and community organizations including the United Way of Greater Greensboro, Family Services of the Piedmont, Hospice Palliative Care of Greensboro, the National Conference of Community of Justice, Triad Stage Theatre and the Sterling South Bank & Trust Company. Presently, Dr. Wos serves on the boards of The Victims of Communism Memorial Foundation, The Institute of World Politics and the Council of American Ambassadors – all headquartered in Washington, DC. Claire Neal, M PH, CHES Executive Director, Triangle Global Health Consortium Claire Neal, MPH is the Executive Director of the Triangle Global Health Consortium (TGHC). TGHC is a non-­‐profit member organization representing some of the best and brightest in global health, including major pharmaceutical companies such as GlaxoSmithKline; leading global health development organizations including founding members RTI International, FHI360, IntraHealth and NC Biotechnology Center; and major academic institutions, such as Duke University, NC State University, and UNC Chapel Hill. Neal has more than 13 years of experience in in the development and delivery of innovative health programs. For the last decade, she worked at the LIVESTRONG Foundation. Most recently Neal was Vice President of Global Strategy where she provided the leadership and vision for LIVESTRONG’s global work. Neal is currently pursuing her Doctor of Public Health (DrPH) at the UNC Gillings School of Global Public Health. She received her MPH from Tulane’s School of Public Health and Tropical Medicine and studied Primary Health Care Management at the ASEAN Institute of Health and Development in Thailand. Neal has a BA in Psychosocial Aspects of Health and Health Care Systems from Duke University. She also served in the Peace Corps in Mali and was selected as an Independent Sector American Express NGen Fellow in 2011. Neal resides in Holly Springs, NC with her husband, Josh, and two sons, Ryan and Jackson. W illiam L. Roper, M D, M PH Stuart Bondurant Professor, Dean and CEO UNC School of Medicine and UNC Health Care The University of North Carolina at Chapel Hill William L. Roper, MD, is dean of the School of Medicine and vice chancellor for Medical Affairs at the University of North Carolina at Chapel Hill (UNC) and CEO of the UNC Health Care System. He also is professor of health policy and management in the School of Public Health, and is professor of pediatrics and of social medicine in the School of Medicine at UNC. From 1997 until 2004, he was dean of the School of Public Health at UNC. Before joining UNC in 1997, Dr. Roper was senior vice president of Prudential HealthCare. He joined Prudential in 1993 as president of the Prudential Center for Health Care Research. Before coming to Prudential, Dr. Roper was director of the Centers for Disease Control and Prevention (CDC), served on the senior White House staff, and was administrator of the Health Care Financing Administration (responsible for Medicare and Medicaid). Earlier, he was a White House Fellow. (Continued) W illiam L. Roper, M D, M PH Stuart Bondurant Professor, Dean and CEO UNC School of Medicine and UNC Health Care The University of North Carolina at Chapel Hill (Continued) Dr. Roper received his MD from the University of Alabama School of Medicine, and his MPH from the University of Alabama at Birmingham School of Public Health. He completed his residency in pediatrics at the University of Colorado Medical Center. Dr. Roper is a member of the Institute of Medicine of the National Academy of Sciences. He is a member of the board of directors of DaVita, Inc., a member of the board of directors of Express Scripts Holding Company, and a member of the board of directors of the National Quality Forum. He lives with his wife Dr. Maryann Roper, a pediatric oncologist, and their son, Will, in Chapel Hill, North Carolina. Kathryn Brinsfield, M D, M PH Assistant Secretary, Office of Health Affairs/Chief Medical Officer (acting), Department of Homeland Security Kathryn Brinsfield, M.D., M.P.H., F.A.C.E.P., serves as the Acting Assistant Secretary of Health Affairs and Acting Chief Medical Officer for the Department of Homeland Security’s (DHS) Office of Health Affairs (OHA). She began her service with DHS in July 2008 and previously served as director of the Division of Workforce Health and Medical Support within OHA. Before joining DHS, Dr. Brinsfield worked for various organizations, including Massachusetts Homeland Security Boston Emergency Services (EMS), Boston Metropolitan Medical Response System (MMRS), and the del Valle Emergency Preparedness Training Institute. Dr. Brinsfield left Boston as an associate professor at the Boston University Schools of Medicine and Public Health with thirteen years of experience as an attending physician at Boston City Hospital/ Boston Medical Center. She graduated with honors from Brown University and received her M.D. from Tufts School of Medicine, and her M.P.H. from Boston University. She completed her residency in Emergency Medicine at Cook County Hospital in Chicago, and her EMS fellowship at Boston EMS. She worked for Boston EMS as director of research, training and quality improvements, medical director for special operations, and associate medical director. She chaired the American College of Emergency Physician’s Disaster Committee, co-­‐chaired the Massachusetts State Surge Committee, assisted in the creation of the Massachusetts Alternate Standards of Care Committee, and was the Commander of the Massachusetts -­‐1 Disaster Medical Assistance Team and a Supervisory Medical Officer for the International Medical and Surgical Response Team, which responded to the September 11th attacks. Jennifer M acFarquhar, R.N., M .P.H., C.I.C. Career Epidemiology Field Officer, Centers for Disease Control and Prevention As a CDC Career Epidemiology Field Officer (CEFO) assigned to the NC DPH, Jennifer MacFarquhar provides leadership, guidance, and direction to strengthen the statewide communicable disease outbreak response, serves as the HAI Prevention Program team lead, and developed an educational curriculum for outbreak management. She served as a CEFO and on a CDC Epidemic Intelligence Service (EIS) fellowship with the TN DOH, working on outbreak investigations, epidemiologic studies, public health surveillance systems, integrated surveillance platform, H1N1 Vaccine Distribution response, and advised the Ministry of Health in Zambia on behalf of the CDC to establish influenza sentinel site surveillance. MacFarquhar received her master’s in public health and a graduate certificate in community preparedness and disaster management from UNC-­‐
CH, and a bachelor of science in nursing from Cedarville University. She has maintained certification in infection control and epidemiology since 2000. Julie Casani, M D, M PH Director of Public Health Preparedness and Response, North Carolina Division of Public Health Julie Casani, MD, is Director of the Public Health Preparedness and Response Program for the North Carolina Department of Health and Human Services (HHS) , overseeing a preparedness system for 85 Local NC Health Departments and 4 regional offices. In this capacity she implements strategic priorities based on a comprehensive system-­‐wide PH Preparedness Capabilities assessment and delivers subject expertise / support to the State Emergency Response Team and Local Health Departments for response to public health emergencies. . She took her M.D. from New York University School of Medicine and a Master’s in Public Health from Johns Hopkins Bloomberg School of Public Health concentration in Health Policy and Management. Dr. Casani serves as Principal Investigator for the CDC Public Health Emergency Preparedness and the U.S Health and Human Services (HHS) Assistant Secretary for Preparedness and Response Cooperative Agreements. She served as Preparedness Director for the Maryland Department of Health and Mental Hygiene from 2000-­‐2006 and coordinated Maryland’s response to the anthrax events of 2001. While serving in Maryland, she implemented a number of enhanced health surveillance systems for Bioterrorism including BioWatch and the National Capitol Region Syndromic Surveillance Project. Chris W oods, M D, M PH Professor of Medicine and Pathology, Duke University Chief of Infectious Diseases and Clinical Microbiology, Durham VA Medical Center Chris Woods, MD, is the Co-­‐Director of the Hubert-­‐Yeargan Center for Global Health. He is an associate professor in the Departments of Medicine and Pathology at Duke University; an adjunct associate professor in Epidemiology at the University of North Carolina at Chapel Hill School of Public Health; an adjunct associate professor in the Emerging Infections Program at the Duke-­‐National University of Singapore Graduate Medical School. Clinically, he serves as Chief of Infectious Diseases and clinical microbiology, and hospital epidemiologist for the Durham VA Medical Center. Dr. Woods is board-­‐certified in internal medicine, infectious diseases, and medical microbiology. Dr. Woods attended Yale University and pursued his medical education and training at Duke University and public health training at UNC-­‐Chapel Hill. He is a graduate of the Epidemic Intelligence Service (EIS) of the Centers for Disease Control and Prevention (CDC), where he served in the Meningitis and Special Pathogens Branch of the National Center for Infectious Diseases. He formulated his interest in global health at Tenwek Hospital in Bomet, Kenya during his internal medicine residency and while at CDC, Dr. Woods performed programmatic work and outbreak investigations throughout the U.S. and the developing world. He currently serves as the Director of Graduate Studies and the MSc for Global Health in the Duke Global Health Institute. Dr. Woods has published over 100 peer-­‐reviewed articles and has a particular interest in development of medical microbiology capacity in the developing world and the epidemiology of emerging and re-­‐emerging infectious diseases. His research focuses on the development of novel diagnostic approaches to infectious disease and the potential for interspecies transmission of pathogens. His genomic approach to harnessing the host response for diagnosis of infectious diseases has been called a paradigm shift in the field. Dr. Woods is a partner in the Southeastern Center for Emerging Biological Threats, core PI of the Southeastern Research Center for Excellence on Emerging Infections and Biodefense, and a leader in the NIH-­‐funded Vaccine and Therapeutics Evaluation Unit at Duke. David J. W eber, M D, M PH, M HA Professor of Medicine and Pediatrics, School of Medicine, UNC Professor of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill Weber is a professor of medicine and pediatrics in the University of North Carolina School of Medicine, and a Professor of Epidemiology in the UNC School of Public Health. He also serves as the medical director of the Departments of Hospital Epidemiology (Infection Control), Occupational Health, and Environmental Health and Safety for the UNC Health Care System. He is an associate director of the North Carolina Statewide Infection Control Program and serves as director of the Regulatory Core for the UNC Clinical Translational Research Award. He is board-­‐certified in internal medicine, infectious disease, critical care medicine, and preventive medicine. (Continued) David J. W eber, M D, M PH, M HA Professor of Medicine and Pediatrics, School of Medicine, UNC Professor of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill (Continued) His research interests include the epidemiology of healthcare-­‐associated infections, new and emerging infectious diseases (Pfisteria, nontuberculous mycobacteria, SAR-­‐coV, norovirus, community-­‐associated MRSA), control of drug resistant pathogens, immunization practices (especially of health-­‐care workers), zoonotic diseases, and epidemiology of tuberculosis. He received his B.A. from Wesleyan University in 1973, his M.D. from the University of California, San Diego, in 1977, his M.P.H. from Harvard University in 1985. He completed his medicine residency and infectious disease fellowship at the Massachusetts General Hospital in 1985. Christopher A. LeGrand, M S President and CEO, Futures Group Chris LeGrand currently serves as president and chief executive officer of Futures Group. Headquartered in Washington, D.C., Futures Group is a global consulting firm that helps to protect and promote people’s well-­‐being around the world. The company has more than 500 staff spanning the United States and more than 35 other countries. LeGrand led a management team that purchased Futures Group as a divestiture from SRA International in September 2008. Previously, LeGrand served as president of Constella Group’s public sector business, a $150M operation with markets in the US and around the world. Constella was aa preeminent provider of integrated health consulting solutions to governments, foundations, and the private sector. Key clients included the US National Institutes of Health, US Centers for Disease Control and Prevention, US Department of Health and Human Services, US Agency for Health and Human Services, US Agency for International Development , other governments and international agencies, and leading global pharmaceutical companies. Prior to running Constella Group’s public sector business, LeGrand held various positions at Constella, including chief operating officer, chief technology officer, and Vice President of the IT and Data Management Division. LeGrand joined Constella in November 1998 and was instrumental driving rapid business growth, including through work with new clients and new service offerings. LeGrand serves on several outside boards in the for-­‐profit and non-­‐profit sectors and currently serves as chair of the Triangle Global Health Consortium board. He has been the recipient of numerous leadership awards, including Business Journal’s top 40 professionals under age 40 in the North Carolina Research Triangle area in 2001, and Business Leader Magazine’s top 100 Business Impact Leaders in the Triangle. He was also honored with the Outstanding Service Award by the Drug Information Association in 2007. LeGrand received a MS Information Management from The George Washington University and a BS in Mathematical Sciences from Clemson University. Donna Altenpohl Vice President, US Policy, GlaxoSmithKline Donna Altenpohl is Vice President for Public Policy for GlaxoSmithKline (GSK), one of the nation’s leading pharmaceutical firms. In this role, she is responsible for developing and executing the company’s public policy strategy, and ensuring that GSK plays a role in positively shaping U.S. legislation, regulation, and the public payer environment so that patients have access to quality healthcare. Altenpohl also leads the company’s healthcare reform and US biosecurity strategies. Altenpohl joined GSK from Cigna in 2006 as executive account manager for the employer segment. In 2008 she was named account vice president of the Center for Medicare and Medicaid Services (CMS) team, which a year later was expanded to include the Department of Health and Human Services (HHS). Altenpohl holds a BA degree from Colby College and is a graduate of the Transformational Leadership for Executives Program, a GSK-­‐sponsored developmental program at the Wharton School of Business at the University of Pennsylvania. An active volunteer in her local education community, Altenpohl is very engaged in fundraising for youth scholarships and local athletics. In 2006, she and her family launched Michelle’s Miles, an annual run and scholarship event that celebrates the life of her daughter. Altenpohl lives in Malvern, Pa. with her husband and their three sons. Jeffrey Spaeder, M D Chief Medical and Scientific Officer, Quintiles Jeffrey A. Spaeder, M.D., is Chief Medical and Scientific Officer for Quintiles. In this role, Dr. Spaeder serves as Quintiles' lead medical expert, representing the company's position on a wide variety of governance, ethical and scientific issues. He chairs Quintiles’ Drug Safety Committee, serves as vice-­‐chair of Quintiles’ Council on Research Ethics, and provides guidance on strategic scientific initiatives. Prior to joining Quintiles, Dr. Spaeder served in increasingly senior roles within the biopharmaceutical industry at Takeda and Abbott Laboratories and was previously a cardiologist at Johns Hopkins Hospital. He has performed research in personalized medicine and novel uses of telemedicine, and holds U.S. patents for medical applications of advanced technologies, telemedicine and information systems. Dr. Spaeder is a graduate of the Pennsylvania State University and the Johns Hopkins University School of Medicine. He also holds a master of business administration (MBA) degree from the Kellogg School of Management at Northwestern University with a concentration in finance. He is a Fellow of the American College of Cardiology and was a Diplomate in cardiovascular disease with the American Board of Internal Medicine. M . M ichelle Berrey, M D, M PH President and Chief Executive Officer, Chimerix, Inc. M. Michelle Berrey, M.D., joined Chimerix in 2012 as Chief Medical Officer (CMO) and was named President and Chief Executive Officer (CEO) in April 2014. Prior to joining Chimerix, Dr. Berrey was CMO at Pharmasset, Inc., a company that focused on the development of nucleotide analogs for the treatment of hepatitis C, from 2007 until its acquisition by Gilead Sciences, Inc. (NASDAQ: GILD) in January 2012. Dr. Berrey's expertise includes the design, early development, medical governance, clinical strategy and product life cycle management of antiviral compounds. Previously, Dr. Berrey served as Vice President, Viral Diseases, Clinical Pharmacology & Discovery Medicine at GlaxoSmithKline, where she was responsible for the early development of compounds for the treatment of HIV, hepatitis viruses and hepatic fibrosis. Dr. Berrey received her MD from the Medical College of Georgia and a Master of Public Health from Emory University. She completed her internship and residency in Internal Medicine at the University of North Carolina at Chapel Hill, and was a Senior Fellow in Infectious Diseases at the University of Washington, Seattle, where she conducted research in HIV transmission and acute HIV infection. She is Board Certified in Internal Medicine and Infectious Diseases. Kate Tulenko, M D, M PH, M phil Vice President, Health Systems Innovation and Director, CapacityPlus Project, IntraHealth International Tulenko is now IntraHealth International’s vice president of health systems innovation, as well as director of CapacityPlus, the USAID-­‐funded and IntraHealth-­‐led global project focused on the health workforce needed to achieve the Millennium Development Goals. In addition to her work at the World Bank, she has been an advisor to national governments on health policy and reform and served on expert panels for the World Health Organization, the American Public Health Association, the Global Health Workforce Alliance, and the American Hospital Association. Tulenko offers consulting services in a variety of fields, including workforce planning and management, health systems innovation and universal access to care. Dykki Settles Director, Health Workforce Informatics and Human Resources Information Systems (HRIS) leader of the CapacityPlus Health Informatics team, IntraHealth International Settle began his career as the first webmaster for the SunSITE project—now www.ibiblio.org, one of the earliest, largest, and longest-­‐running online libraries of open resources. But he dreamed about how open-­‐source approaches could be game-­‐
changers in developing countries. What if, instead of paying steep licensing fees or struggling to glean information from paper records, developers could freely use and modify software to help solve entrenched data problems? Today, Settle leads IntraHealth International and CapacityPlus’s efforts in health worker informatics bringing a health worker-­‐centered approach to the availability and use of high-­‐quality information. Settle offers consulting services in developing and implementing open-­‐source information solutions for human resources for health; helping countries build capacity for new health technologies; and supporting regional and country health organizations to realize the power of open-­‐source technology for global health. W illiam A. Fischer II, M D Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine The University of North Carolina School of Medicine William Fischer, II, is associate program director for research in the department of medicine’s division of pulmonary diseases and critical care medicine. Billy (as he is known) grew up in Chapel Hill, N.C., and has always been particularly interested in infectious diseases. He went to UNC School of Medicine and then was a medicine resident, chief resident, and pulmonary and critical care fellow at Johns Hopkins Hospital. During his training Billy worked at the U.S. Centers for Disease Control and Prevention and the World Health Organization (WHO). In June, Dr. Fischer was asked by WHO to help work on emerging pathogens and he has been sent to Guinea to work with Doctors without Borders (Médecins Sans Frontières or MSF) to try to help reduce mortality from Ebola Virus in rural communities. Dr. Fischer lives in Chapel Hill, N.C., with his wife, Leah, and two sons. Lyttelton Braim a Rotary Peace Fellow I spent the last five years working for the World Bank’s Justice for the Poor (J4P) Program, e-­‐folioa global research and development program that seeks to understand how governance and justice systems function at the local level, and uses these findings to inform policy and program intervention. During this period, I had the privilege of leading research projects and evaluation studies in the mining, local governance, justice, and health sectors of Sierra Leone, as well as opportunities to design and implement social accountability and community-­‐based conflict resolution and peace-­‐building programs. I am one of the few researchers around the world who has in-­‐depth experience and expertise with qualitative case tracking, a methodology that has been recognized as one of the key ways of assessing the impact of legal empowerment interventions. I have implemented every aspect of this method firsthand, from designing data collection instruments, to extracting random samples from case dockets, to finding and interviewing subjects, to analyzing and reporting. I have managed teams of field researchers to apply this method and have advised teams in Kenya, Indonesia and the Philippines. Prior to joining the World Bank, I worked for Care International, a non-­‐profit organization working at the intersection of social enterprise, public health and community development in rural Sierra Leone. As a Program Officer in Care’s Rights Based Approach (RBA) program, I spent over four years working on agrarian livelihood and community education programs in the South and Northern regions; mobilizing peasant farmers, raising awareness on rights, and conducting training on improved farming practices, conflict mitigation/resolution, and civic engagement for community cohesion. My experience working in these fields over the years has led me to the conclusion that societies with high power imbalances, where the socio-­‐legal landscape is complex with multiple and often inadequately integrated rule systems, reforming governance and justice is essential both for reducing poverty and preventing violent conflict.